drugset / Trial / NCT04566211
Comparing the Efficacy of 10-day Reverse Hybrid Therapy and 10-day Triple Therapy Plus Bismuth Therapy.
RandomizedParallel-groupSingle-blindTreatment
Summary
Reverse hybrid therapy achieves a higher eradication rate than triple therapy plus bismuth therapy remains unanswered.
Timeline
- Start
- 2020-01-01
- Primary completion
- 2022-09-30
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 1 g | — |
| Comparator | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Metronidazole | Small molecule | 500 mg | — |
| Comparator | Pantoprazole | Other / unclassified | 40 mg | — |
| Comparator | bismuth subcitrate | Unknown | 240 mg | — |